(Q41060557)

26 September 2017

title

Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status (English)

1 reference

26 September 2017

1 reference

Kane GC

1

1 reference

26 September 2017

Varga J

2

1 reference

26 September 2017

Conant EF

3

1 reference

26 September 2017

Spirn PW

4

1 reference

26 September 2017

Jimenez S

5

1 reference

26 September 2017

Fish JE

6

1 reference

26 September 2017

publication date

1 April 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

90

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

223-230

1 reference

Predictors of survival in systemic sclerosis (scleroderma)

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

The pulmonary pathologic manifestations of the CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Are ACA and Scl 70 antibodies mutually exclusive?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

The effect of D-penicillamine on pulmonary findings in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Pulmonary function in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2896%2990291-7

7 January 2021

10.1016/S0954-6111(96)90291-7

Identifiers

DOI

1 reference

26 September 2017

1 reference